RDY 250 (Terbinafine 250 mg)
Pill imprint RDY 250 has been identified as Terbinafine 250 mg.
Terbinafine is used in the treatment of onychomycosis, toenail; tinea capitis; cutaneous candidiasis; tinea corporis; tinea cruris (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Terbinafine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- RDY 250
- 250 mg
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|54569-5944||A-S Medication Solutions, LLC (repackager)|
|21695-0630||Rebel Distributors Corp (repackager)|
More about terbinafine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 214 Reviews – Add your own review/rating
- Drug class: miscellaneous antifungals
- Terbinafine Hydrochloride (AHFS Monograph)
- Terbinafine (FDA)
- Terbinafine (Systemic) (Wolters Kluwer)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.